Live Breaking News & Updates on Prnewswire Actinium Pharmaceuticals Inc

Stay updated with breaking news from Prnewswire actinium pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Actinium Pharma (ATNM) Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML

Actinium Pharma (ATNM) Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Glasgow City , Hannah Choe , European Bone Marrow Transplant Society Meeting , Professor Of Medicine At Ohio State University , Prnewswire Actinium Pharmaceuticals Inc , Overall Survival , Antibody Radiation Conjugates , Complete Remission , Assistant Professor , Ohio State University , Annual Meeting ,

Actinium Announces Clinical Trial to Study Iomab-ACT Targeted Radiotherapy Conditioning with Leading FDA Approved Commercial CAR T-Cell Therapy

Potential blockbuster opportunity for next-generation targeted radiotherapy conditioning with CAR T-cell therapy a multi-billion market with six FDA approved. ....

United States , Avinash Desai , Sandesh Seth , Exchange Commission , Actimaba National Cancer Institute , Actinium Pharmaceuticals Inc , Prnewswire Actinium Pharmaceuticals Inc , International Blood Marrow Transplant Research , American Society For Transplantation , Antibody Radiation Conjugates , Texas Southwestern Medical Center , Chief Medical Officer , Memorial Sloan Kettering , B Cell Acute Lymphoblastic Leukemia , Diffuse Largeb Cell Lymphoma , Cellular Therapy Meetings , American Society , Cellular Therapy , International Blood , Marrow Transplant Research , Actinium Pharmaceuticals , National Cancer Institute ,

Actinium Highlights Improved Survival with Iomab-B in TP53 Positive Relapsed Refractory Acute Myeloid Leukemia Patients in the SIERRA Trial and Other Presentations at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®

Iomab-B significantly improved outcomes in TP53 positive patients with a median overall survival of 5.49 months versus 1.66 months in those not receiving Iomab-B (hazard ratio = 0.23, p-value=0.0002) in ....

United States , San Antonio , Avinash Desai , International Blood Marrow Transplant Research , American Society For Transplantation , Actimaba National Cancer Institute , Marrow Transplant Research , Exchange Commission , Actinium Pharmaceuticals Inc , International Blood , Prnewswire Actinium Pharmaceuticals Inc , Cellular Therapy , American Society , Complete Remission , Chief Medical Officer , Iomabb Phase , Apamistamab Improves Outcomes , Targeted Myeloablative Radiation Using , Apamistamab Prior , Allogeneic Hematopoietic Cell Transplant , B Cell Acute Lymphoblastic Leukemia , Diffuse Largeb Cell , Tandem Meetingsi Transplantation , Cellular Therapy Meetings , Actinium Pharmaceuticals , National Cancer Institute ,

Actinium Announces Iomab-B Produces High Response Rates and Significant Improvement in Overall Survival in Relapsed Refractory AML Patients with Active Disease Overcoming TP53 Mutation

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today. ....

United States , Hannah Choe , Astellas Pharma , Avinash Desai , American Society Of Hematology Meeting Exposition , Professor Of Medicine At Ohio State University , Prnewswire Actinium Pharmaceuticals Inc , Oncology Lg Chem Life Sciences , Actimaba National Cancer Institute , Exchange Commission , Actinium Pharmaceuticals Inc , Overall Survival , Annual American Society , Hematology Meeting , Complete Remission , Assistant Professor , Ohio State University , Chief Medical Officer , Pivotal Phase , About Actinium Pharmaceuticals , National Cancer Institute , Life Sciences , Actinium Pharmaceuticals , Health Care Amp Hospitals , Pharmaceuticals , Medical Pharmaceuticals ,

Actinium's Four Presentations at ASH Highlight the Positive Outcomes for Iomab-B and Actimab-A in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Actinium's Four Presentations at ASH Highlight the Positive Outcomes for Iomab-B and Actimab-A in Patients with Relapsed or Refractory Acute Myeloid Leukemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Sandesh Seth , Astellas Pharma , Oncology Lg Chem Life Sciences , Actimaba National Cancer Institute , Actinium Pharmaceuticals Inc , Prnewswire Actinium Pharmaceuticals Inc , American Society Of Hematology Annual Meeting Exposition , Exchange Commission , Annual American Society , Hematology Annual Meeting , Multiple High Risk , Complete Remission , Karnofsky Performance Status , Dose Targeted Radiation , Apamistamab Prior , Durable Complete Remission , Actinium Pharmaceuticals , National Cancer Institute , Life Sciences , Mutated Acute Myeloid Leukemia , Onco Targets ,